Let's catch up on the latest news from the stock market. From significant investments to major deals and earnings announced on May 21 to earnings announcements expected today (May 22), here's a quick look at which stocks will be in focus in trade on Wednesday.
Grasim Industries, Sun Pharmaceutical Industries, Power Grid Corporation of India, One 97 Communications (Paytm), FSN E-Commerce Ventures (Nykaa), Ashoka Buildcon, Dhanlaxmi Bank, GE Power India, Gland Pharma, GMM Pfaudler, Garden Reach Shipbuilders & Engineers, HEG, Jubilant FoodWorks, Minda Corporation, New India Assurance Company, Petronet LNG, Sundram Fasteners, Torrent Power, and Unichem Laboratories will announce their March quarter earnings on May 22.
Earnings Announced Post Market Hours on May 21
BHEL Q4 (Consolidated YoY)
Profit falls 25.6% to Rs 489.6 crore Vs Rs 658 crore
Revenue rises 0.4% to Rs 8,260.3 crore Vs Rs 8,227 crore
PI Industries Q4 (Consolidated YoY)
Profit jumps 31.7% to Rs 369.5 crore Vs Rs 280.6 crore
Revenue increases 11.2% to Rs 1,741 crore Vs Rs 1,565.6 crore
Gulf Oil Lubricants India Q4 (Consolidated YoY)
Profit spikes 38.7% to Rs 86.2 crore Vs Rs 62.2 crore
Revenue rises 9.8% to Rs 869.6 crore Vs Rs 792 crore
Ramco Systems Q4 (Consolidated YoY)
Net loss narrows to Rs 23 crore Vs loss of Rs 45.4 crore
Revenue grows 4% to Rs 131.2 crore Vs Rs 126.2 crore
Maharashtra Seamless Q4 (Consolidated YoY)
Profit drops 41.4% to Rs 218.3 crore Vs Rs 372.7 crore
Revenue declines 25.6% to Rs 1,214.9 crore Vs Rs 1,632.9 crore
Morepen Laboratories Q4 (Consolidated YoY)
Profit jumps 243.2% to Rs 28.3 crore Vs Rs 8.2 crore
Revenue rises 16.3% to Rs 423.07 crore Vs Rs 363.7 crore
Tilaknagar Industries Q4 (Consolidated YoY)
Profit tanks 46.8% to Rs 31.5 crore Vs Rs 59.1 crore
Revenue rises 0.4% to Rs 358.8 crore Vs Rs 357.4 crore
Sheela Foam Q4 (Consolidated YoY)
Profit jumps 49.5% to Rs 65.2 crore Vs Rs 43.6 crore
Revenue rises 16% to Rs 845.2 crore Vs Rs 729 crore
Metropolis Healthcare Q4 (Consolidated YoY)
Profit increases 9.2% to Rs 36.4 crore Vs Rs 33.3 crore
Revenue up 17.1% at Rs 331 crore Vs Rs 282.5 crore
Core business revenue up 15% at Rs 308 crore Vs Rs 267 crore
Laxmi Organic Industries Q4 (Consolidated YoY)
Profit jumps 82.2% to Rs 44.3 crore Vs Rs 24.3 crore
Revenue grows 8.4% to Rs 792 crore Vs Rs 730.5 crore
Religare Enterprises Q4 (Consolidated YoY)
Profit plunges 96.4% to Rs 125.1 crore Vs Rs 3,481.8 crore
Exceptional gain at Rs 230.3 crore Vs Rs 3,289.4 crore
Revenue grows 33% to Rs 1,855.7 crore Vs Rs 1,396 crore
Hitachi Energy India Q4 (Consolidated YoY)
Profit jumps 123.7% to Rs 113.7 crore Vs Rs 50.8 crore
Revenue rises 27% to Rs 1,695.3 crore Vs Rs 1,334 crore
Ircon International Q4 (Consolidated YoY)
Profit declines 3.8% to Rs 246.7 crore Vs Rs 256.5 crore
Revenue slips 1% to Rs 3,742.7 crore Vs Rs 3,780.7 crore
Action Construction Equipment Q4 (Consolidated YoY)
Profit spikes 106.6% to Rs 98.4 crore Vs Rs 47.7 crore
Revenue increases 36.2% to Rs 835.8 crore Vs Rs 613.8 crore
JK Tyre and Industries Q4 (Consolidated YoY)
Profit zooms 56.2% to Rs 169.3 crore Vs Rs 108.4 crore
Revenue increases 1.8% to Rs 3,698.5 crore Vs Rs 3,632.5 crore
Va Tech Wabag Q4 (Consolidated YoY)
Profit at Rs 72.4 crore Vs loss of Rs 111 crore
Revenue rises 0.8% to Rs 934.2 crore Vs Rs 926.9 crore
Eris Lifesciences Q4 (Consolidated YoY)
Profit increases 8.5% to Rs 71 crore Vs Rs 65.4 crore
Revenue surges 36.8% to Rs 550.9 crore Vs Rs 402.8 crore
Godawari Power & Ispat Q4 (Consolidated YoY)
Profit jumps 29% to Rs 220 crore Vs Rs 170 crore
Revenue advances 16% to Rs 1,530 crore Vs Rs 1,317 crore
Stocks To Watch
The pharma company has received final approval from the US Food and Drug Administration (US FDA) for Abbreviated New Drug Application (ANDA) for Pregabalin capsules. This approval pertains to a generic equivalent of the Reference Listed Drug, Lyrica capsules, of Upjohn US 2 LLC. Pregabalin is used for neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, and fibromyalgia.
Warburg Pincus's arm is likely to sell a 3.5% stake in Apollo Tyres for Rs 1,040 crore. White Iris Investment, a subsidiary of Warburg Pincus, will conduct the sale on May 22 through a block deal, aiming to raise Rs 1,040 crore. The deal size is 2.24 crore shares, reports CNBC Awaaz quoting sources.
The company has been declared as the lowest bidder for two EPC road projects of MSRDC (Maharashtra State Road Development Corporation), with a quoted price of Rs 4,994 crore.
The company has emerged as the L1 bidder for two road projects worth Rs 4,346.14 crore of Maharashtra State Road Development Corporation.
Company's subsidiary, Biocon Biologics, has obtained approval from the US Food and Drug Administration (US FDA) for the first-to-file application for Yesafili, an interchangeable biosimilar aflibercept. Yesafili, a vascular endothelial growth factor (VEGF) inhibitor, is utilized in the treatment of various ophthalmology conditions.
The Water Resources Department has issued a notice to United Spirits, demanding payment of water charge arrears totaling Rs 345.45 crore for the period spanning from November 2018 to April 2024 in Nanded, Maharashtra. The notice, issued under section 49(j) of the Maharashtra Irrigation Act, 1976, mandates payment within 7 days of receipt to avoid stoppage of water supply.
Indian Emulsifiers
The trading in company's equity shares will commence on the NSE Emerge with effect from May 22. The issue price has been fixed at Rs 132 per share. Its equity shares will be available for trading in the trade-for-trade surveillance segment.
HDFC Bank has exited Protean eGov Technologies by selling its entire shareholding of 12,94,326 equity shares at an average price of Rs 1,160.15 per share via open market transactions, amounting to Rs 150.16 crore. Nippon India Mutual Fund A/C - Nippon India Small Cap Fund purchased 12,78,312 equity shares (3.16% of paid-up equity) at an average price of Rs 1,160 per share, totaling Rs 148 crore.
Aptus Value Housing Finance India
East Bridge Capital Master Fund I and SBI Mutual Fund bought 2,25,50,721 equity shares in the housing finance company (equivalent to 4.8% of paid-up equity) at an average price of Rs 294 per share, valuing at Rs 662.99 crore. Promoter Westbridge Crossover Fund LLC sold 2,47,73,019 equity shares in Aptus at an average price of Rs 294.15 per share. Additionally, another promoter, JIH II LLC, exited the company by selling its entire shareholding of 1,01,53,093 equity shares at an average price of Rs 294.73 per share.
F&O Ban
Indian Energy Exchange, National Aluminium Company, Punjab National Bank, Aditya Birla Capital, Balrampur Chini Mills, Bandhan Bank, Biocon, GMR Airports Infrastructure, Granules India, Vodafone Idea, India Cements, Piramal Enterprises, and Zee Entertainment Enterprises.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
